Sight Sciences Inc (SGHT)

Apr 15, 2026

Sight Sciences wins $34M patent ruling against Alcon - MSN

Apr 15, 2026

Apr 14, 2026

KCK LTD. Significantly Reduces Stake in Sight Sciences Inc - GuruFocus

Apr 14, 2026

Apr 13, 2026

SGHT: Momentum builds for interventional glaucoma and dry eye, with innovation and adoption accelerating - TradingView — Track All Markets

Apr 13, 2026

Apr 12, 2026

If You Invested $1,000 in Sight Sciences, Inc. (SGHT) - Stock Titan

Apr 12, 2026

Apr 12, 2026

Form 4Statement of changes in beneficial ownership of securities - ADVFN

Apr 12, 2026

Apr 09, 2026

Sight Sciences CLO Hayden sells shares worth $48,851 By Investing.com - Investing.com India

Apr 09, 2026

Apr 09, 2026

Sight Sciences CLO Hayden sells shares worth $48,851 - Investing.com

Apr 09, 2026

Apr 09, 2026

Sight Sciences CFO Rodberg sells $25,670 in shares - Investing.com

Apr 09, 2026

Apr 09, 2026

Sight Sciences CFO Rodberg sells $25,670 in shares By Investing.com - Investing.com Canada

Apr 09, 2026

Apr 09, 2026

Sight Sciences (NASDAQ: SGHT) CFO sells 7,231 shares to cover RSU taxes - Stock Titan

Apr 09, 2026

Apr 09, 2026

Sight Sciences (SGHT) legal chief sells 13,761 shares for RSU tax obligations - Stock Titan

Apr 09, 2026

Apr 08, 2026

KCK Ltd. reports 1.44M shares in Sight Sciences (SGHT) — 2.7% stake - Stock Titan

Apr 08, 2026

Apr 08, 2026

Bull Bear: Does ITRI offer margin of safetyWeekly Profit Analysis & Smart Investment Allocation Tips - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Cuts Target Price to $4.35 - Moomoo

Apr 07, 2026

Apr 06, 2026

Affiliate notice: SGHT (NASDAQ: SGHT) proposes common-share sale tied to vesting - Stock Titan

Apr 06, 2026

Apr 06, 2026

SGHT (NASDAQ: SGHT) sale notice: 13,761 restricted shares vesting - Stock Titan

Apr 06, 2026

Apr 05, 2026

Published on: 2026-04-05 14:40:16 - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026

Apr 04, 2026

Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) - Investing.com Australia

Apr 04, 2026

Apr 03, 2026

Insider Selling: Sight Sciences (NASDAQ:SGHT) CTO Sells 8,168 Shares of Stock - MarketBeat

Apr 03, 2026

Apr 03, 2026

Taylor, EVP, operations & R&D, sells $10.6k in Sight Sciences (SGHT) By Investing.com - Investing.com South Africa

Apr 03, 2026

Apr 03, 2026

Sight Sciences (NASDAQ:SGHT) EVP Brenton Taylor Sells 2,869 Shares - MarketBeat

Apr 03, 2026

Apr 03, 2026

Sight Sciences (NASDAQ:SGHT) CEO Sells 29,244 Shares - MarketBeat

Apr 03, 2026

Apr 03, 2026

Sight Sciences CEO Badawi sells $108k in shares By Investing.com - Investing.com India

Apr 03, 2026

Apr 03, 2026

[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan

Apr 03, 2026

Apr 03, 2026

Sight Sciences CEO Badawi sells $108k in shares - Investing.com

Apr 03, 2026

Apr 03, 2026

Sight Sciences (SGHT) CTO tax-related sale of 8,168 shares disclosed - Stock Titan

Apr 03, 2026

Apr 03, 2026

Sight Sciences (SGHT) EVP Brenton sells 2,869 shares for RSU tax obligations - Stock Titan

Apr 03, 2026

Apr 02, 2026

Sight Sciences executive plans $90K stock sale - National Today

Apr 02, 2026

Apr 02, 2026

Alison Bauerlein plans sale of 25,874 shares (SGHT) - Stock Titan

Apr 02, 2026

Apr 02, 2026

Insider sale notice: SGHT (NASDAQ: SGHT) 8,168 restricted shares - Stock Titan

Apr 02, 2026

Apr 02, 2026

SGHT PE Ratio & Valuation, Is SGHT Overvalued - Intellectia AI

Apr 02, 2026

Apr 01, 2026

Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - The Manila Times

Apr 01, 2026

Apr 01, 2026

Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to Be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - 富途牛牛

Apr 01, 2026

Apr 01, 2026

SGHT (NASDAQ: SGHT) files Form 144 to sell 29,244 vested shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Proposed share sales at SGHT (NASDAQ: SGHT) include 2,293 and 576 shares - Stock Titan

Apr 01, 2026

Mar 31, 2026

Aug Rallies: Is Sight Sciences Inc a top pick in the sectorTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Sight Sciences wins $34M in Alcon patent case, ongoing royalty By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Sight Sciences Wins $34 Million Patent Infringement Case Against Alcon, Secures Ongoing Royalties Through 2028 - Minichart

Mar 31, 2026

Mar 30, 2026

Sight Sciences wins $34M in Alcon patent case, ongoing royalty - Investing.com Australia

Mar 30, 2026

Mar 30, 2026

Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th - GlobeNewswire

Mar 30, 2026

Mar 30, 2026

Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud - Law360

Mar 30, 2026

Mar 30, 2026

Lake Street Maintains Sight Sciences(SGHT.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Mar 30, 2026

Mar 30, 2026

Published on: 2026-03-31 02:42:17 - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Sight Sciences U.S. district court issued order on post-trial motions in patent infringement case against Alcon originally filed on Sep 16, 2021 - marketscreener.com

Mar 30, 2026